Cytodyn, this company must have some kind of fanta
Post# of 148297
(Total Views: 729)
Posted On: 11/17/2020 4:56:35 PM
Cytodyn, this company must have some kind of fantastic drug.
They are going thru millions of dollars every month paying Dr Nader and other medical doctors on staff, overhead expenses, costs of trials, loan payments, and yet investors continue to loan them money to continue. No revenue yet, no sales, no profits, but MDs and PhDs choose to be on staff and with Cytodyn, rather than working somewhere else or working as a medical doctor in private practice. All these credentialed folks, Cytodyn's survival, the millions of dollars they owe Samsung and 2 loans @ $28 million each, it all depends upon performance of 1 drug, leronlimab. You don't just keep all this going unless you truly have a home run drug....for covid, HIV, cancer, NASH, longhaulers and more. If the drug wasn't very probably a home run, staff would be leaving the company, due to doubts. And surely, these folks are beyond "belief" in leronlimab, IMO, they "know". OK, so I'd guess the pessimist could claim that their huge salaries could be the primary motive for hanging in, waiting for approvals, and/or expectations of bonuses based on future profits.
They are going thru millions of dollars every month paying Dr Nader and other medical doctors on staff, overhead expenses, costs of trials, loan payments, and yet investors continue to loan them money to continue. No revenue yet, no sales, no profits, but MDs and PhDs choose to be on staff and with Cytodyn, rather than working somewhere else or working as a medical doctor in private practice. All these credentialed folks, Cytodyn's survival, the millions of dollars they owe Samsung and 2 loans @ $28 million each, it all depends upon performance of 1 drug, leronlimab. You don't just keep all this going unless you truly have a home run drug....for covid, HIV, cancer, NASH, longhaulers and more. If the drug wasn't very probably a home run, staff would be leaving the company, due to doubts. And surely, these folks are beyond "belief" in leronlimab, IMO, they "know". OK, so I'd guess the pessimist could claim that their huge salaries could be the primary motive for hanging in, waiting for approvals, and/or expectations of bonuses based on future profits.
(2)
(1)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼